Breaking News

Rentschler Appoints CBO

March 7, 2013

Ternes brings 25 years of experience

Frank Ternes has been appointed chief business officer, responsible for leading the planning, development and execution of all business development, sales, marketing and project management activities at Rentschler Biotechnologie.
Mr. Ternes has more than 25 years of experience from operations and technology positions at Boehringer Ingelheim, where he last served as senior vice president of Biopharmaceutical Contract Manufacturing.
"Mr. Ternes is an excellent addition to Rentschler's management board," says Dr. Nikolaus F. Rentschler, chief executive officer and owner of Rentschler. "With his broad experience in the contract manufacturing business, he has a keen understanding of technology, a strong customer focus, and a proven track record for achieving success.”
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus